Anaesthetic management of myasthenia gravis in coronary artery bypass grafting

Autor: M. O. Maybauer, Vinayak Vanjari
Rok vydání: 2020
Předmět:
Male
lcsh:Diseases of the circulatory (Cardiovascular) system
Weakness
Midazolam
Myocardial Infarction
Case Report
rocuronium
Anesthesia
General
030204 cardiovascular system & hematology
Neuromuscular junction
Sugammadex
lcsh:RD78.3-87.3
03 medical and health sciences
0302 clinical medicine
030202 anesthesiology
Coronary artery bypass graft
medicine
Humans
General anaesthesia
Coronary Artery Bypass
Rocuronium
Propofol
Aged
myasthenia gravis
Neuromuscular Blockade
Morphine
business.industry
General Medicine
Neuromuscular monitoring
medicine.disease
Myasthenia gravis
Analgesics
Opioid
Fentanyl
Anesthesiology and Pain Medicine
medicine.anatomical_structure
lcsh:Anesthesiology
lcsh:RC666-701
Anesthesia
medicine.symptom
Cardiology and Cardiovascular Medicine
business
Anesthetics
Intravenous
Neuromuscular Nondepolarizing Agents
medicine.drug
Zdroj: Annals of Cardiac Anaesthesia
Annals of Cardiac Anaesthesia, Vol 23, Iss 2, Pp 209-211 (2020)
ISSN: 0971-9784
DOI: 10.4103/aca.aca_176_18
Popis: Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction causing weakness and fatigability of muscles. Careful perioperative management is required because of the unpredictable susceptibility to muscle relaxants. In this case report, we describe the successful management of a MG patient for normothermic coronary artery bypass graft (CABG) surgery with titrated doses of rocuronium without prolonged postoperative ventilation. We chose rocuronium because full and rapid recovery of neuromuscular blockade is possible with sugammadex. We conclude that using rocuronium is safe during general anaesthesia in MG patients undergoing on-pump CABG when combined with continuous neuromuscular monitoring and careful perioperative management.
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje